For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Acelrx Pharmaceuticals, Inc.

USPTO Granted Patents = 26

CIPO Patents = 3

EPO Patents = 11

Trademarks = 4

Forward Citations = 1,150

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Andrew I Poutiatine (24 out of 43 patents)

Pamela Palmer (22 out of 34 patents)

Thomas A Schreck (21 out of 29 patents)

4. Stelios Tzannis (19 out of 27 patents)

5. Larry Hamel (15 out of 16 patents)

6. Charles Rampersaud (13 out of 17 patents)

7. Bruce P Edwards (11 out of 41 patents)

8. Edmond Chiu (6 out of 8 patents)

9. Lawrence Hamel (5 out of 5 patents)

10. William Kolosi (5 out of 17 patents)

11. Sascha Retailleau (5 out of 8 patents)

12. Benjamin K Yaffe (3 out of 31 patents)

13. Bradley Blackwood (3 out of 14 patents)

14. Casidy Domingo (1 out of 4 patents)

15. Shamim Pushpala (1 out of 2 patents)

26 patents: Sort by Forward Citations

1. 11058856 - Systems, devices and methods for dispensing oral transmucosal dosage forms (2021-07-13),

2. 10896751 - Storage and dispensing devices for administration of oral transmucosal dosage forms (2021-01-19),

3. 10709881 - Apparatus for administering small volume oral transmucosal dosage forms (2020-07-14),

4. 10507180 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2019-12-17),

5. 10342762 - Small-volume oral transmucosal dosage forms (2019-07-09),

6. 10245228 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2019-04-02),

7. 9744129 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2017-08-29),

8. 9642996 - Methods and apparatus for administering small volume oral transmucosal dosage forms (2017-05-09),

9. 9320710 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2016-04-26),

10. 9289583 - Methods for administering small volume oral transmucosal dosage forms using a dispensing device (2016-03-22),

11. 8945592 - Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same (2015-02-03),

12. 8905964 - Drug storage and dispensing devices and systems comprising the same (2014-12-09),

13. 8865743 - Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain (2014-10-21),

14. 8865211 - Bioadhesive drug formulations for oral transmucosal delivery (2014-10-21),

15. 8778394 - Small-volume oral transmucosal dosage forms (2014-07-15),

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. Their proprietary technology platform, DSUVIATM, delivers non-invasive, rapid-onset pain relief for patients in medically supervised settings. AcelRx is dedicated to improving patient care by providing effective and convenient pain management solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

26 Patents

#74 in Redwood City, CA

#2,960 in California

#12,451 in US

#24,093 in the World

Redwood City, CA, United States of America

Acelrx Pharmaceuticals, Inc.

Forward Citations = 1,150

17 inventors:

Andrew I Poutiatine (24 out of 43 patents)

Pamela Palmer (22 out of 34 patents)

Thomas A Schreck (21 out of 29 patents)

4. Stelios Tzannis (19 out of 27 patents)

5. Larry Hamel (15 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…